These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 32310047)

  • 21. microRNAs as pharmacological targets in cancer.
    Soriano A; Jubierre L; Almazán-Moga A; Molist C; Roma J; de Toledo JS; Gallego S; Segura MF
    Pharmacol Res; 2013 Sep; 75():3-14. PubMed ID: 23537752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
    Kaboli PJ; Rahmat A; Ismail P; Ling KH
    Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
    Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
    Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
    Mirzaei S; Zarrabi A; Asnaf SE; Hashemi F; Zabolian A; Hushmandi K; Raei M; Goharrizi MASB; Makvandi P; Samarghandian S; Najafi M; Ashrafizadeh M; Aref AR; Hamblin MR
    Life Sci; 2021 Mar; 268():119005. PubMed ID: 33421526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.
    Çetinkaya M; Baran Y
    Curr Pharm Biotechnol; 2023; 24(7):913-925. PubMed ID: 35927824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The therapeutic potential of microRNAs: disease modulators and drug targets.
    McDermott AM; Heneghan HM; Miller N; Kerin MJ
    Pharm Res; 2011 Dec; 28(12):3016-29. PubMed ID: 21818713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of miRNAs in combined cancer therapy.
    Yu HW; Cho WC
    Expert Opin Biol Ther; 2015 Jul; 15(7):923-5. PubMed ID: 25813091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.
    Bayraktar R; Van Roosbroeck K
    Cancer Metastasis Rev; 2018 Mar; 37(1):33-44. PubMed ID: 29282605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R; Hussey DJ; Haier J
    Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA in cancer: new hopes for antineoplastic chemotherapy.
    Di Leva G; Briskin D; Croce CM
    Ups J Med Sci; 2012 May; 117(2):202-16. PubMed ID: 22348396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
    Yamamoto H; Mori M
    Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of Extracellular RNAs in Oncology.
    Thompson JR; Zhu J; Kilari D; Wang L
    Mol Diagn Ther; 2017 Feb; 21(1):1-11. PubMed ID: 27688207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
    Cuciniello R; Filosa S; Crispi S
    J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathways: microRNAs as cancer therapeutics.
    Melo SA; Kalluri R
    Clin Cancer Res; 2012 Aug; 18(16):4234-9. PubMed ID: 22711704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNAs in cancer management.
    Kong YW; Ferland-McCollough D; Jackson TJ; Bushell M
    Lancet Oncol; 2012 Jun; 13(6):e249-58. PubMed ID: 22652233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives.
    Tutar L; Tutar E; Özgür A; Tutar Y
    Drug Dev Res; 2015 Nov; 76(7):382-8. PubMed ID: 26435382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs as novel targets and tools in cancer therapy.
    Abba ML; Patil N; Leupold JH; Moniuszko M; Utikal J; Niklinski J; Allgayer H
    Cancer Lett; 2017 Feb; 387():84-94. PubMed ID: 27045478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.